Bacteriophage salmonella solution for oral administration, 100ml

• Diseases or carriers of bacteria caused by salmonella of the above serotypes.

An important condition for effective phage therapy is a preliminary determination of phage sensitivity and early use of the drug.

The drug is intended for internal use. For treatment, bacteriophage is taken 3 times a day through the mouth 1 hour before meals from the first day of the disease for 7-10 days. In case of a disease characterized by a mild colitis syndrome, and during the period of convalescence, simultaneously with oral administration, it is recommended to inject the drug rectally, in the form of enemas, instead of 1 dose by mouth.

For prophylactic purposes, the drug is recommended to be used to prevent bacterial carriers, nosocomial infection, during group diseases in organized groups and families. The optimal use regimen is a daily single dose, depending on age. The duration of taking the drug is determined by the conditions of the epidemiological situation.

Composition. 1 ml of the drug contains the active substance - sterile filtrate of salmonella phagolysates: gr. A - Salmonella paratyphi A; gr. B - S. paratyphi B, S. typhimurium, S. heidelberg; gr. C- S.newport, S.choleraesuis,

S. oranienburg, S. infantis; rp. D-S. dublin, S. enteritidis; gr. E- S.anatum, S.newlands - up to 1 ml.

Excipients: Preservative - 8-hydroxyquinoline sulfate - 0.0001 g / ml (calculated content); or 8-hydroxyquinoline sulfate monohydrate - 0.0001 g / ml (in terms of 8-hydroxyquinoline sulfate, calculated content).

None.

Clinical and pharmacological group: Immunobiological preparation - bacteriophage

Pharmaco-therapeutic group: MIBP-bacteriophage

pharmachologic effect

The drug causes specific lysis of Salmonella of the above serotypes.

Indications of the drug Bacteriophage salmonella groups A, B, C, D, E liquid

• diseases or carriers of bacteria caused by salmonella of the above serotypes.

An important condition for effective phage therapy is a preliminary determination of phage sensitivity and early use of the drug.

Dosage regimen

The drug is intended for internal use. For treatment, bacteriophage is taken 3 times a day through the mouth 1 hour before meals from the first day of the disease for 7-10 days. In case of a disease characterized by a mild colitis syndrome, and during the period of convalescence, simultaneously with oral administration, it is recommended to inject the drug rectally, in the form of enemas, instead of 1 dose by mouth.

For prophylactic purposes, the drug is recommended to be used to prevent bacterial carriers, nosocomial infection, during group diseases in organized groups and families. The optimal use regimen is a daily single dose, depending on age. The duration of taking the drug is determined by the conditions of the epidemiological situation.

Side effect

Not installed.

Contraindications for use

None.

Application in children

Can be used in children according to indications.

special instructions

Shake the bottle with liquid bacteriophage before use. If cloudy, do not use!

Influence on the ability to drive vehicles and use mechanisms

The use of the drug does not affect the ability to drive vehicles, mechanisms.

Overdose

Not installed.

Drug interactions

The use of the drug is possible in combination with other drugs, including antibiotics.

Storage conditions of the drug Bacteriophage salmonella groups A, B, C, D, E liquid

Storage in accordance with SP 3.3.2.1248-03 at a temperature of 2 to 8 ? C in a dry, dark place out of the reach of children.

Shelf life of the drug Bacteriophage salmonella groups A, B, C, D, E liquid

Shelf life is 2 years.

Terms of sale

Without recipe.